ANBT
NEO icon

American National Bank & Trust’s NeoGenomics NEO Stock Holding History

American National Bank & Trust’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-304
Closed -$3.74K – 641
2023
Q3 		$3.74K Buy
+304
New +$4.52K ﹤0.01% 483

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

American National Bank & Trust's NEO Position: Q4 2023 in Review

American National Bank & Trust sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 304 shares — an estimated $3.74K sold.

American National Bank & Trust first reported a position in NEO in Q3 2023 and held it in 1 quarter. The position peaked at $3.74K in Q3 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • American National Bank & Trust reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • American National Bank & Trust sold 304 NeoGenomics shares in Q4 2023, an estimated $3.74K.
  • American National Bank & Trust first reported a position in NeoGenomics in Q3 2023 and held it in 1 quarter.
  • American National Bank & Trust's NeoGenomics position peaked at $3.74K in Q3 2023.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on American National Bank & Trust's 13F filing for Q4 2023, filed 8 Feb 2024.